-
Product Insights
NewAngiopoietin Related Protein 3 – Drugs In Development, 2024
The Angiopoietin Related Protein 3 pipeline drugs market research report outlays comprehensive information on the Angiopoietin Related Protein 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, and Musculoskeletal Disorders which include indications of Homozygous Familial Hypercholesterolemia (HoFH), Hypertriglyceridemia, Atherosclerosis, Unspecified Cardiovascular Disorders, and Osteoarthritis. It also reviews key players involved in Angiopoietin Related...
-
Product Insights
NewLow Density Lipoprotein Receptor Related Protein – Drugs In Development, 2024
The Low Density Lipoprotein Receptor Related Protein pipeline drugs market research report outlays comprehensive information on the Low Density Lipoprotein Receptor Related Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Central Nervous System, Musculoskeletal Disorders, and Respiratory which include indications of Optic Nerve Injury, Diabetic Retinopathy, Alzheimer's Disease, Multiple Sclerosis, Osteoporosis, Osteonecrosis, Idiopathic Pulmonary Fibrosis,...
-
Product Insights
NewCarcinoembryonic Antigen Related Cell Adhesion Molecule 5 – Drugs In Development, 2024
The Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 pipeline drugs market research report outlays comprehensive information on the Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Metastatic Colorectal Cancer. It also reviews key players involved in Carcinoembryonic Antigen Related Cell Adhesion Molecule...
-
Product Insights
NewCarcinoembryonic Antigen Related Cell Adhesion Molecule 1 – Drugs In Development, 2024
The Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 pipeline drugs market research report outlays comprehensive information on the Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Melanoma. It also reviews key players involved in Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 targeted...
-
Product Insights
NewCell Division Cycle 7 Related Protein Kinase – Drugs In Development, 2024
The Cell Division Cycle 7 Related Protein Kinase pipeline drugs market research report outlays comprehensive information on the Cell Division Cycle 7 Related Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Ovarian Cancer, and Pancreatic Cancer. It also reviews key players involved in Cell Division Cycle 7 Related Protein Kinase...
-
Product Insights
NewNuclear Factor Erythroid 2 Related Factor 2 – Drugs In Development, 2024
The Nuclear Factor Erythroid 2 Related Factor 2 pipeline drugs market research report outlays comprehensive information on the Nuclear Factor Erythroid 2 Related Factor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Gastrointestinal, and Ophthalmology which include indications of Multiple Sclerosis, Unspecified Neurologic Disorders, Oncology, Breast Cancer, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Ulcerative...
-
Product Insights
NewParathyroid Hormone/Parathyroid Hormone Related Peptide Receptor – Drugs In Development, 2024
The Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor pipeline drugs market research report outlays comprehensive information on the Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hormonal Disorders, Musculoskeletal Disorders, Oncology, and Genetic Disorders which include indications of Hypoparathyroidism, Primary Hyperparathyroidism, Osteoporosis, Post Menopausal Osteoporosis, Humoral Hypercalcemia of Malignancy, and Mutational Disorders....
-
Product Insights
NewCalcitonin Gene Related Peptide Type 1 Receptor – Drugs In Development, 2024
The Calcitonin Gene Related Peptide Type 1 Receptor pipeline drugs market research report outlays comprehensive information on the Calcitonin Gene Related Peptide Type 1 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Dermatology, Undisclosed, and Cardiovascular which include indications of Migraine, Cluster Headache Syndrome (Cluster Headache), Diabetic Foot Ulcers, Rosacea, Unspecified, and Resistant...
-
Product Insights
NewMas Related G Protein Coupled Receptor MRG – Drugs In Development, 2024
The Mas Related G Protein Coupled Receptor MRG pipeline drugs market research report outlays comprehensive information on the Mas Related G Protein Coupled Receptor MRG targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Genetic Disorders, Central Nervous System, and Musculoskeletal Disorders which include indications of Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory...
-
Product Insights
NewLow Density Lipoprotein Receptor Related Protein 5 – Drugs In Development, 2024
The Low Density Lipoprotein Receptor Related Protein 5 pipeline drugs market research report outlays comprehensive information on the Low Density Lipoprotein Receptor Related Protein 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Gastrointestinal, Musculoskeletal Disorders, and Oncology which include indications of Diabetic Macular Edema, Diabetic Retinopathy, Inflammatory Bowel Disease, Bone Disorders, and Solid Tumor. It...